Merger - Additional Information (Details) $ / shares in Units, $ in Thousands			12 Months Ended
	Feb. 10, 2021 USD ($) $ / shares shares	Oct. 20, 2020 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares	Dec. 31, 2020 USD ($)	[1]	Mar. 26, 2021 $ / shares
Business Acquisition [Line Items]
Stock issued during the period, value			$ 3,787	$ 135,657
Payment of underwriter fees and other offering costs			(23,913)
Private Placement [Member]
Business Acquisition [Line Items]
Shares Issued Price Per Share | $ / shares		$ 10.00
Forward Purchase Warrants [Member]
Business Acquisition [Line Items]
Warrants issued during the period | shares		833,333
Panacea [Member]
Business Acquisition [Line Items]
Payment of underwriter fees and other offering costs			(2,500)
Accretion Expense			$ 100
Common Class A [Member]
Business Acquisition [Line Items]
Stock issued during the period, shares | shares		47,655,000
Shares Issued Price Per Share | $ / shares		$ 10.00	$ 11.50			$ 10.28
Stock issued during the period, value		$ 476,600
Stock conversion ratio	0.196
Common Stock Voting Rights	one vote per share
Common Class A [Member] | Private Placement [Member]
Business Acquisition [Line Items]
Stock issued during the period, shares | shares		2,500,000
Stock issued during the period, value		$ 25,000
Common Class A [Member] | Panacea [Member]
Business Acquisition [Line Items]
Stock redeemed during the period, shares | shares	3,350
Common stock redemption price per share | $ / shares	$ 10.00
Stock redeemed or called during period, value	$ 30
Common Class B [Member]
Business Acquisition [Line Items]
Stockholders Equity Note Stock Split Conversion Ratio1	0.196
Founder Shares Conversion | shares	1,000,000

[1] Reflected net of deemed dividend and beneficial conversion feature (see note 8)